CRNX
Price
$33.76
Change
+$0.24 (+0.72%)
Updated
May 2 closing price
Capitalization
3.16B
4 days until earnings call
TVTX
Price
$21.15
Change
+$0.39 (+1.88%)
Updated
May 2 closing price
Capitalization
1.88B
88 days until earnings call
Ad is loading...

CRNX vs TVTX

Header iconCRNX vs TVTX Comparison
Open Charts CRNX vs TVTXBanner chart's image
Crinetics Pharmaceuticals
Price$33.76
Change+$0.24 (+0.72%)
Volume$907.55K
Capitalization3.16B
Travere Therapeutics
Price$21.15
Change+$0.39 (+1.88%)
Volume$2.33M
Capitalization1.88B
CRNX vs TVTX Comparison Chart
Loading...
CRNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TVTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CRNX vs. TVTX commentary
May 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRNX is a Buy and TVTX is a Buy.

Ad is loading...
COMPARISON
Comparison
May 04, 2025
Stock price -- (CRNX: $33.76 vs. TVTX: $21.15)
Brand notoriety: CRNX and TVTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRNX: 87% vs. TVTX: 135%
Market capitalization -- CRNX: $3.16B vs. TVTX: $1.88B
CRNX [@Biotechnology] is valued at $3.16B. TVTX’s [@Biotechnology] market capitalization is $1.88B. The market cap for tickers in the [@Biotechnology] industry ranges from $306.3B to $0. The average market capitalization across the [@Biotechnology] industry is $2.29B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRNX’s FA Score shows that 0 FA rating(s) are green whileTVTX’s FA Score has 0 green FA rating(s).

  • CRNX’s FA Score: 0 green, 5 red.
  • TVTX’s FA Score: 0 green, 5 red.
According to our system of comparison, TVTX is a better buy in the long-term than CRNX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRNX’s TA Score shows that 7 TA indicator(s) are bullish while TVTX’s TA Score has 5 bullish TA indicator(s).

  • CRNX’s TA Score: 7 bullish, 3 bearish.
  • TVTX’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, CRNX is a better buy in the short-term than TVTX.

Price Growth

CRNX (@Biotechnology) experienced а +4.23% price change this week, while TVTX (@Biotechnology) price change was +15.38% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.30%. For the same industry, the average monthly price growth was +8.07%, and the average quarterly price growth was -4.75%.

Reported Earning Dates

CRNX is expected to report earnings on Aug 08, 2025.

TVTX is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (+4.30% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRNX($3.16B) has a higher market cap than TVTX($1.88B). TVTX YTD gains are higher at: 21.412 vs. CRNX (-33.972). TVTX has higher annual earnings (EBITDA): -265.77M vs. CRNX (-336.07M). CRNX has more cash in the bank: 1.35B vs. TVTX (371M). CRNX has less debt than TVTX: CRNX (51.7M) vs TVTX (402M). TVTX has higher revenues than CRNX: TVTX (233M) vs CRNX (1.04M).
CRNXTVTXCRNX / TVTX
Capitalization3.16B1.88B168%
EBITDA-336.07M-265.77M126%
Gain YTD-33.97221.412-159%
P/E RatioN/AN/A-
Revenue1.04M233M0%
Total Cash1.35B371M365%
Total Debt51.7M402M13%
FUNDAMENTALS RATINGS
CRNX vs TVTX: Fundamental Ratings
CRNX
TVTX
OUTLOOK RATING
1..100
3045
VALUATION
overvalued / fair valued / undervalued
1..100
90
Overvalued
90
Overvalued
PROFIT vs RISK RATING
1..100
5577
SMR RATING
1..100
7798
PRICE GROWTH RATING
1..100
6236
P/E GROWTH RATING
1..100
10042
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CRNX's Valuation (90) in the Pharmaceuticals Major industry is in the same range as TVTX (90) in the Biotechnology industry. This means that CRNX’s stock grew similarly to TVTX’s over the last 12 months.

CRNX's Profit vs Risk Rating (55) in the Pharmaceuticals Major industry is in the same range as TVTX (77) in the Biotechnology industry. This means that CRNX’s stock grew similarly to TVTX’s over the last 12 months.

CRNX's SMR Rating (77) in the Pharmaceuticals Major industry is in the same range as TVTX (98) in the Biotechnology industry. This means that CRNX’s stock grew similarly to TVTX’s over the last 12 months.

TVTX's Price Growth Rating (36) in the Biotechnology industry is in the same range as CRNX (62) in the Pharmaceuticals Major industry. This means that TVTX’s stock grew similarly to CRNX’s over the last 12 months.

TVTX's P/E Growth Rating (42) in the Biotechnology industry is somewhat better than the same rating for CRNX (100) in the Pharmaceuticals Major industry. This means that TVTX’s stock grew somewhat faster than CRNX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CRNXTVTX
RSI
ODDS (%)
Bullish Trend 3 days ago
80%
Bearish Trend 3 days ago
89%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 3 days ago
84%
Momentum
ODDS (%)
Bullish Trend 3 days ago
77%
Bullish Trend 3 days ago
77%
MACD
ODDS (%)
Bullish Trend 3 days ago
88%
Bullish Trend 3 days ago
83%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
79%
Bullish Trend 3 days ago
78%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
78%
Bullish Trend 3 days ago
79%
Advances
ODDS (%)
Bullish Trend 3 days ago
77%
Bullish Trend 5 days ago
79%
Declines
ODDS (%)
Bearish Trend 19 days ago
80%
Bearish Trend about 1 month ago
78%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
77%
Bearish Trend 3 days ago
82%
Aroon
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 3 days ago
84%
View a ticker or compare two or three
Ad is loading...
CRNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TVTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BSFIX30.420.75
+2.53%
Baron Small Cap Instl
VSCIX106.292.32
+2.23%
Vanguard Small Cap Index I
TPYCX8.860.17
+1.96%
Touchstone Sands Capital Intl Gr Eq C
SWMIX21.870.41
+1.91%
Schwab International Opportunities
ECLCX27.100.42
+1.57%
Eaton Vance Growth C

CRNX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRNX has been loosely correlated with XNCR. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if CRNX jumps, then XNCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRNX
1D Price
Change %
CRNX100%
+0.72%
XNCR - CRNX
53%
Loosely correlated
+3.68%
TRDA - CRNX
53%
Loosely correlated
+1.99%
DNLI - CRNX
52%
Loosely correlated
+2.37%
RVMD - CRNX
52%
Loosely correlated
+0.20%
ETNB - CRNX
51%
Loosely correlated
+7.38%
More

TVTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, TVTX has been loosely correlated with CRNX. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if TVTX jumps, then CRNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TVTX
1D Price
Change %
TVTX100%
+1.88%
CRNX - TVTX
43%
Loosely correlated
+0.72%
COGT - TVTX
42%
Loosely correlated
+4.26%
XNCR - TVTX
42%
Loosely correlated
+3.68%
BHVN - TVTX
41%
Loosely correlated
+1.78%
RLAY - TVTX
39%
Loosely correlated
-1.22%
More